Surgery Partners(US:SGRY)2026-03-02 22:11Financial Performance - Surgery Partners, Inc. reported net losses of $77.9 million in 2025, $168.1 million in 2024, and $11.9 million in 2023, indicating ongoing challenges in achieving profitability [137]. - As of December 31, 2025, the company had approximately $3.7 billion in total indebtedness, including $1.4 billion in senior secured term loans and $1.225 billion in senior unsecured notes due 2032 [138]. - The company had $692.8 million available for additional borrowings under its revolving credit facility after accounting for $11.0 million in outstanding letters of credit [149]. - The company holds U.S. federal net operating loss carryforwards of approximately $532.4 million and state NOL carryforwards of approximately $657.1 million, which may be subject to limitations due to ownership changes [156]. Cybersecurity and Compliance - Cybersecurity incidents have been a concern, with a minor incident in May 2023 temporarily disrupting operations in Idaho, highlighting the need for robust information security measures [159]. - The company maintains cybersecurity insurance, but coverage may be insufficient to offset potential losses from cyber incidents [160]. - The company may face significant penalties for non-compliance with state and federal privacy laws, with California's laws imposing fines of up to $250,000 for violations [162]. - The company is subject to numerous federal and state regulations, and failure to comply could result in substantial civil or criminal penalties, loss of licenses, and exclusion from government health programs [166]. - Violations of self-referral laws could incur civil monetary penalties of up to $15,000 per prohibited service billed and exclusion from Medicare and Medicaid programs [177]. - The company’s management agreements may not fully comply with the Anti-Kickback Statute, exposing it to potential legal challenges and penalties [174]. - The company’s patient assistance programs may need restructuring if found inconsistent with applicable laws, potentially leading to significant penalties [184]. Regulatory and Legal Risks - Changes to the Affordable Care Act, including the expiration of premium caps for subsidies on December 31, 2025, are expected to lead to increased premiums and decreased patient volumes, adversely affecting revenues [165]. - The Affordable Care Act restricts the expansion of physician-owned hospitals, limiting the ability to increase the number of inpatient beds and operating rooms [178]. - The company is under increased scrutiny from federal and state audits, which could lead to significant penalties for false claims or improper billing practices [179]. - The company is currently facing audits from RAC, MIC, and ZPIC, which could have a material adverse effect on its business and financial condition due to unresolved appeals and potential future audits [186]. - The company is involved in various lawsuits and claims that could result in substantial costs and divert resources, potentially affecting its business condition [187]. - The company has received threats of claims from former employees regarding labor and employment regulations, which could lead to significant financial liabilities [188]. - The company may face large malpractice claims that could result in significant damages not covered by insurance, impacting its financial condition [189]. - Regulatory scrutiny in healthcare transactions may hinder the company's ability to acquire or expand surgical facilities, impacting growth strategies [195]. - Antitrust enforcement could pose risks if the company is found to have a concentrated market share or engages in illegal negotiating practices, adversely affecting its operations [196]. Ownership and Governance - The largest stockholder, Bain Capital, owns approximately 38.6% of the company’s outstanding common stock, significantly influencing corporate decisions [198]. - Provisions in the company’s charter may deter beneficial takeover efforts, potentially limiting stockholder value [199]. Financial Risks - The company is exposed to interest rate risk due to variable rate indebtedness, which could increase debt service obligations if interest rates rise [154]. - Significant operating and financial restrictions are imposed by the company's senior indebtedness, potentially limiting operational flexibility and capital raising efforts [143]. - The company has intercompany loans totaling $44.2 million, which could impact financial condition if the surgical facilities are unable to repay these loans [151]. - Future ownership changes may further restrict the ability to utilize net operating loss carryforwards, affecting tax liabilities [156]. - Medicare payments to the company could be reduced if it fails to meet quality metrics, which poses a risk to its revenue [193].